Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 23, 2008 09:00 ET | Source: Hemispherx Biopharma, Inc.

Japanese NIH Scientists Report Robust Cross-Protection With Hemispherx Drug Against Multiple Strains of Bird Flu

PHILADELPHIA, Sept. 23, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) reported that at the Third European Influenza Conference in Portugal (September 14-17, 2008), members of the...
September 17, 2008 16:30 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. Adjourns Stockholder Meeting Due to Lack of a Quorum to October 17, 2008

PHILADELPHIA, Sept. 17, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that it adjourned its annual stockholders' meeting, held today, to Friday, October 17, 2008 at...
September 03, 2008 09:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma to Present At BioPharm America Conference

PHILADELPHIA, Sept. 3, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that the Company will present at the BioPharm America Conference to be held on September 9 to 10,...
August 12, 2008 11:39 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. Releases Financial Results for the Three Months Ended June 30, 2008

PHILADELPHIA, Aug. 12, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced its financial results for the fiscal quarter ended June 30, 2008. The net loss including non-cash...
July 15, 2008 09:30 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma to Host Investor Conference Call On Chronic Fatigue Syndrome NDA Filing

PHILADELPHIA, July 15, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that it has scheduled an investor conference call and webcast to take place on Thursday, July 17,...
July 14, 2008 09:30 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. Announces Settlement of All Bioclones/Ribotech Litigation

PHILADELPHIA, July 14, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that all outstanding legal issues between Hemispherx and Bioclones (Proprietary), Ltd. and...
July 08, 2008 09:45 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma's Ampligen NDA for Chronic Fatigue Syndrome Accepted for Review by the FDA

PHILADELPHIA, July 8, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today reported that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's New Drug...
June 16, 2008 08:30 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. Announces Settlement of Arbitration With Laboratorios del Dr. Esteve

PHILADELPHIA, June 16, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that the arbitration proceeding between Hemispherx and Laboratorios del Dr. Esteve ("Esteve") has...
June 02, 2008 09:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. Completes Enrollment in Phase II Study of Ampligen as Seasonal Flu Vaccine Enhancer

PHILADELPHIA, June 2, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today reported that it has completed enrollment in a Phase II clinical trial to evaluate the safety and efficacy of...
May 13, 2008 09:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. Releases Financial Results for the Three Months Ended March 31, 2008

PHILADELPHIA, May 13, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced its financial results for the fiscal quarter ended March 31, 2008. The net loss for this period was...